Claya review
Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.
- Scores never bought
- 537 providers tracked
- Every factor auditable
- Updated August 2026
Semaglutide here is $325/mo — $126 above our category median of $199.
- Semaglutide
- $325/mo
- Tirzepatide
- $434/mo
- Coverage
- Coverage not published
- Brand-name
- Compounded only
- Oral option
- Yes
- Verification
- Not independently listed
Best for: People who want compounded GLP-1 in injectable and oral-tablet forms with named clinicians.
MatchScript's take: Our #242 pick of 537 — one of the few with a non-injection route.
The factor breakdown
Claya on the six Match Score factors — the same sub-scores the quiz reweights to your priorities. See the methodology.
Semaglutide from $325/mo puts Budget Fit at a below-par 37 — above the budget tiers.
Limited or undisclosed state coverage can slow your start, for a below-par 60 on Speed to Start.
Claya adds an oral/sublingual route on top of injectables, for a middling 77 on Formulary Match.
Support lands at a middling 78 — lighter, meds-first support.
Flexibility scores a below-par 61 — fewer levers to flex your plan.
Thinner public disclosure than the top of the ranking keeps Transparency at a below-par 72.
Pricing in context
How Claya's monthly price sits against the category median and the cheapest provider we track.
What we like
- Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
- Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
- Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
- Weight-loss money-back guarantee published on the homepage
- Free expedited shipping included in the monthly price
The caveats
- States-served list not disclosed — you must check at checkout
- LegitScript certification status not displayed
- Corporate legal entity not disclosed on the site or privacy policy
- Oral compounded tablets have weaker efficacy data than injectable semaglutide
- Intro pricing is higher at refill ($299), erasing the first-month advantage
Who it's for — and who should skip it
Claya is for people who want compounded GLP-1 in injectable and oral-tablet forms with named clinicians.
Skip it if that doesn't sound like you. A closer fit may be SkinnyRx (Match Score 64) — or take the quiz to see where Claya lands for your priorities.
How it compares to CoreAge Rx & the closest scorer
Claya against our #1 overall pick and the provider that scores closest to it. Green marks the row leader.
| How it compares | Clayathis provider | CoreAge Rxour #1 | SkinnyRxclosest scorer |
|---|---|---|---|
| Sema price | $325/mo | $99/mo at every dose | $354/mo |
| Coverage | Coverage not published | All 50 states | 47 states + DC |
| Formulary | Injectable + oral | Injectable | Injectable + oral |
| Match Score | 64 · C | 91 · A− | 64 · C |
Claya, answered
Is Claya legit?
Claya is a real, operating GLP-1 telehealth program. LegitScript certification is the third-party check worth asking for — look for the seal on their site and confirm your prescriber is US-licensed at intake. Like most programs here it dispenses compounded GLP-1s, which are made by a licensed pharmacy but aren't FDA-approved.
How much does Claya cost?
Claya lists compounded semaglutide from $325/mo and tirzepatide from $434/mo — above our category median of $199/mo. These are the provider's public figures at our last review (August 2026); confirm on their site, since some teaser tiers step up after month one.
Does Claya ship to my state?
Claya doesn't publish a full state list, so confirm your state is covered during intake before you pay.
Claya vs SkinnyRx — which should I pick?
They score within a few points of each other: Claya at 64/100 and SkinnyRx at 64/100, so neither wins on the headline number. Claya is the better fit for people who want compounded GLP-1 in injectable and oral-tablet forms with named clinicians. SkinnyRx suits shoppers who want a tablet as well as an injection on either molecule, and who read the term attached to an advertised rate before they read the number. Run the quiz and the weighting shifts to whichever of those matters more to you.
Pricing & state data last verified August 2026 from Claya's public site and our master provider matrix. The Match Score and its sub-scores are our editorial judgment per the methodology. Commercial facts only — prices change, so confirm on Claya's site. Not medical advice; see our disclosure.
Semaglutide here is $325/mo — $126 above our category median of $199. Tirzepatide is $434/mo. It scores highest on the care that comes after the first vial. Best suited to people who want compounded GLP-1 in injectable and oral-tablet forms with named clinicians. If that is not you, SkinnyRx is the closest thing to it here.
Compare with other providers
Our next-best picks in default ranking order, then the 24 programs that sit nearest Claya here.
- #1Match91/ 100CoreAge RxThe best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.91/100
- #2Match84/ 100Strut HealthThe only program here carrying both LegitScript and ACHC accreditation, with an oral lozenge route on both molecules at the cheapest entry in this ranking.84/100
- #3Match83/ 100EdenA polished, high-disclosure compounded program with strong nationwide coverage and hands-on support.83/100
- #4Match85/ 100RoA heavyweight telehealth brand with brand-name access and a polished experience — but opaque compounded pricing.85/100
- #5Match85/ 100No BS RXThe highest Transparency score here, and it is not close: twenty-four prices on one public page and four dispensing pharmacies named with street addresses.85/100
Compare 24 nearby providersHide them
| Provider | Tirzepatide price | Coverage | Alternatives | Go | ||
|---|---|---|---|---|---|---|
| Injectco#243 | 64 | $156/mo (compounded) | $431/mo | Coverage not published | Alternatives | Visit |
| TeleCareSpot#244 | 64 | $303/mo | $405/mo | 48 states | Alternatives | Visit |
| YOURx Health#245 | 64 | $169/mo | $192/mo | Coverage not published | Alternatives | Visit |
| Calibrate Health#246 | 64 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| Cost Plus Drugs#247 | 64 | $279/mo (brand Ozempic) | Not disclosed | All 50 states | Alternatives | Visit |
| Curve#248 | 64 | $175/mo (compounded) | $225/mo (compounded) | All 50 states | Alternatives | Visit |
| Framework#249 | 64 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| GetRelief Rx#250 | 64 | $212/mo | $364/mo | Coverage not published | Alternatives | Visit |
| Tell Her Doc#251 | 64 | $269/mo (microdose tier, plus a separate fee, compounded) | Not disclosed | All 50 states | Alternatives | Visit |
| Arc-1#252 | 64 | $200/mo (0.5 mg dose, compounded) | $200/mo (2.5 mg dose, compounded) | Coverage not published | Alternatives | Visit |
| WePeptideRx#253 | 64 | $189/mo | $202/mo | Coverage not published | Alternatives | Visit |
| TelePeptide#254 | 64 | $199/mo (starting dose, annual plan, compounded oral) | $249/mo | Coverage not published | Alternatives | Visit |
| VitaFusions IV#255 | 64 | $149/mo (all doses, plus a separate fee, compounded) | $192/mo | Coverage not published | Alternatives | Visit |
| Roen Rx#256 FDA issued Roen Health, Inc. dba RoenRx a warning letter in June 2026. See FDA's warning-letter database. | 64 | $151/mo (3-month plan, plus a separate fee, compounded) | $456/mo | Coverage not published | Alternatives | Visit |
| Alinwell#257 | 64 | $249/mo (charged every 30 days; the advertised rate is a first-month price) | $299/mo (charged every 30 days; the advertised rate is a first-month price) | All 50 states | Alternatives | Visit |
| Boston Medical Group#258 | 63 | $325/mo | $253/mo | 7 states | Alternatives | Visit |
| WeightRx#259 | 63 | $250/mo (compounded) | $83/mo (term not published, compounded) | Coverage not published | Alternatives | Visit |
| HeliMeds#260 | 63 | $260/mo | $162/mo | Coverage not published | Alternatives | Visit |
| AZ Health#261 | 63 | $179/mo (all doses, compounded) | $249/mo | Coverage not published | Alternatives | Visit |
| NP2GO#262 | 63 | $183/mo | $283/mo | 40 states | Alternatives | Visit |
| Options Medical Weight Loss#263 | 63 | $271/mo | $379/mo | Coverage not published | Alternatives | Visit |
| Cielo#264 | 63 | $141/mo | $192/mo | Coverage not published | Alternatives | Visit |
| Eloria#265 | 63 | $299/mo | Not disclosed | Coverage not published | Alternatives | Visit |
| AskRx#266 | 63 | $349/mo (all doses, brand-name) | $299/mo (2.5 mg dose, brand-name) | All 50 states | Alternatives | Visit |
Claya is ranked on our best semaglutide providers, best tirzepatide providers, best GLP-1 programs and best oral GLP-1 providers boards, scored on the same six factors as every other provider there.